{
    "medicine_id": "127e1c45eb15c2514c3faec4a9dac1c171ed9d18",
    "platform_id": "DB00933",
    "metadata": {
        "name": "Serentil 100 mg 1 Tablet film coated",
        "composition": "100 mg 1 Mesoridazine",
        "clinical_particulars": {
            "therapeutic_indications": "Used in the treatment of schizophrenia organic brain disorders alcoholism and psychoneuroses",
            "contraindications": {
                "disease": "Oral LD sub 50 sub is 560 plusmn 62 5 mg kg and 644 plusmn 48 mg kg in mouse and rat respectively Symptoms of overdose may include emesis muscle tremors decreased food intake and death associated with aspiration of oral gastric contents into the respiratory system",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Mesoridazine the besylate salt of a metabolite of thioridazine is a phenothiazine tranquilizer Pharmacological studies in laboratory animals have established that mesoridazine has a spectrum of pharmacodynamic actions typical of a major tranquilizer In common with other tranquilizers it inhibits spontaneous motor activity in mice prolongs thiopental and hexobarbital sleeping time in mice and produces spindles and block of arousal reaction in the EEG of rabbits It is effective in blocking spinal reflexes in the cut and antagonizes d amphetamine excitation and toxicity in grouped mice It shows a moderate adrenergic blocking activity in vitro and in vivo and antagonizes 5 hydroxytryptamine in vivo Intravenously administered it lowers the blood pressure of anesthetized dogs It has a weak antiacetylcholine effect in vitro",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB09083",
                        "description": "Ivabradine may increase the QTc prolonging activities of Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00921",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Buprenorphine"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "Doxylamine may increase the central nervous system depressant CNS depressant activities of Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00470",
                        "description": "Dronabinol may increase the central nervous system depressant CNS depressant activities of Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "Droperidol may increase the central nervous system depressant CNS depressant activities of Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00956",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Hydrocodone"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "The therapeutic efficacy of Mesoridazine can be increased when used in combination with Magnesium sulfate"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Methotrimeprazine"
                    },
                    {
                        "drugbank-id": "DB01017",
                        "description": "Minocycline may increase the central nervous system depressant CNS depressant activities of Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "Mirtazapine may increase the central nervous system depressant CNS depressant activities of Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00486",
                        "description": "Nabilone may increase the central nervous system depressant CNS depressant activities of Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Orphenadrine"
                    },
                    {
                        "drugbank-id": "DB09117",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Paraldehyde"
                    },
                    {
                        "drugbank-id": "DB08883",
                        "description": "Perampanel may increase the central nervous system depressant CNS depressant activities of Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "Mesoridazine may increase the sedative activities of Rotigotine"
                    },
                    {
                        "drugbank-id": "DB06201",
                        "description": "The risk or severity of adverse effects can be increased when Rufinamide is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB09072",
                        "description": "Sodium oxybate may increase the central nervous system depressant CNS depressant activities of Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Suvorexant"
                    },
                    {
                        "drugbank-id": "DB06204",
                        "description": "Tapentadol may increase the central nervous system depressant CNS depressant activities of Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Thalidomide"
                    },
                    {
                        "drugbank-id": "DB00425",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Zolpidem"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "Mesoridazine may increase the antipsychotic activities of Amisulpride"
                    },
                    {
                        "drugbank-id": "DB00422",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Methylphenidate"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Dexmethylphenidate"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of adverse effects can be increased when Metoclopramide is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB09097",
                        "description": "The therapeutic efficacy of Quinagolide can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "Mesoridazine may increase the antipsychotic activities of Sulpiride"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The risk or severity of adverse effects can be increased when Methadone is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB14507",
                        "description": "Lithium citrate may increase the neurotoxic activities of Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB14506",
                        "description": "Lithium hydroxide may increase the neurotoxic activities of Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "Mesoridazine may increase the arrhythmogenic activities of Mequitazine"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Thiopental"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Dicoumarol"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Phenindione"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Warfarin"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Phenprocoumon"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Acenocoumarol"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with 4 hydroxycoumarin"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Coumarin"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with R warfarin"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Ethyl biscoumacetate"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Fluindione"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Clorindione"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Diphenadione"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Tioclomarol"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with S Warfarin"
                    },
                    {
                        "drugbank-id": "DB00765",
                        "description": "The risk or severity of extrapyramidal symptoms and CNS depression can be increased when Metyrosine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Ethanol"
                    },
                    {
                        "drugbank-id": "DB00972",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Azelastine"
                    },
                    {
                        "drugbank-id": "DB00484",
                        "description": "Brimonidine may increase the central nervous system depressant CNS depressant activities of Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB04832",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Zimelidine"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Dapoxetine"
                    },
                    {
                        "drugbank-id": "DB06731",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Seproxetine"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Sertraline"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Sibutramine"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Nefazodone"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Milnacipran"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Desvenlafaxine"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Levomilnacipran"
                    },
                    {
                        "drugbank-id": "DB08953",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Indalpine"
                    },
                    {
                        "drugbank-id": "DB13233",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Alaproclate"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "The serum concentration of Esmolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "The serum concentration of Betaxolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00335",
                        "description": "The serum concentration of Atenolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "The serum concentration of Timolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "The serum concentration of Propranolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "The serum concentration of Labetalol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "The serum concentration of Bisoprolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "The serum concentration of Alprenolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "The serum concentration of Pindolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "The serum concentration of Carvedilol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "The serum concentration of Acebutolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "The serum concentration of Nadolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01295",
                        "description": "The serum concentration of Bevantolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01297",
                        "description": "The serum concentration of Practolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "The serum concentration of Penbutolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "The serum concentration of Oxprenolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB03322",
                        "description": "The serum concentration of Dexpropranolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "The serum concentration of Celiprolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB04861",
                        "description": "The serum concentration of Nebivolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB06726",
                        "description": "The serum concentration of Bufuralol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB08807",
                        "description": "The serum concentration of Bopindolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "The serum concentration of Bupranolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "The serum concentration of Indenolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB09204",
                        "description": "The serum concentration of Arotinolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB09351",
                        "description": "The serum concentration of Levobetaxolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "The serum concentration of Talinolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "The serum concentration of Anisodamine can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB12752",
                        "description": "The serum concentration of Bucindolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13443",
                        "description": "The serum concentration of Esatenolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13508",
                        "description": "The serum concentration of Cloranolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13530",
                        "description": "The serum concentration of Mepindolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13757",
                        "description": "The serum concentration of Epanolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13775",
                        "description": "The serum concentration of Tertatolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB12212",
                        "description": "The serum concentration of Landiolol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Morphine"
                    },
                    {
                        "drugbank-id": "DB00318",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Codeine"
                    },
                    {
                        "drugbank-id": "DB00327",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Hydromorphone"
                    },
                    {
                        "drugbank-id": "DB00497",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Oxycodone"
                    },
                    {
                        "drugbank-id": "DB00611",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Butorphanol"
                    },
                    {
                        "drugbank-id": "DB00647",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Dextropropoxyphene"
                    },
                    {
                        "drugbank-id": "DB00652",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Pentazocine"
                    },
                    {
                        "drugbank-id": "DB00704",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00708",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Sufentanil"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Alfentanil"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Fentanyl"
                    },
                    {
                        "drugbank-id": "DB00844",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00854",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Levorphanol"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Remifentanil"
                    },
                    {
                        "drugbank-id": "DB01081",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Diphenoxylate"
                    },
                    {
                        "drugbank-id": "DB01192",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Oxymorphone"
                    },
                    {
                        "drugbank-id": "DB01209",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Dezocine"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Levacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01433",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Methadyl acetate"
                    },
                    {
                        "drugbank-id": "DB01450",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Dihydroetorphine"
                    },
                    {
                        "drugbank-id": "DB01452",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Diamorphine"
                    },
                    {
                        "drugbank-id": "DB01459",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Bezitramide"
                    },
                    {
                        "drugbank-id": "DB01466",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Ethylmorphine"
                    },
                    {
                        "drugbank-id": "DB01497",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Etorphine"
                    },
                    {
                        "drugbank-id": "DB01529",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Dextromoramide"
                    },
                    {
                        "drugbank-id": "DB01531",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Desomorphine"
                    },
                    {
                        "drugbank-id": "DB01535",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Carfentanil"
                    },
                    {
                        "drugbank-id": "DB01551",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Dihydrocodeine"
                    },
                    {
                        "drugbank-id": "DB01555",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Alphacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01565",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Dihydromorphine"
                    },
                    {
                        "drugbank-id": "DB06738",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Ketobemidone"
                    },
                    {
                        "drugbank-id": "DB08861",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with DPDPE"
                    },
                    {
                        "drugbank-id": "DB09174",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Lofentanil"
                    },
                    {
                        "drugbank-id": "DB09272",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Eluxadoline"
                    },
                    {
                        "drugbank-id": "DB11130",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Opium"
                    },
                    {
                        "drugbank-id": "DB11609",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Normethadone"
                    },
                    {
                        "drugbank-id": "DB12492",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Piritramide"
                    },
                    {
                        "drugbank-id": "DB13160",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Alphaprodine"
                    },
                    {
                        "drugbank-id": "DB13454",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Nicomorphine"
                    },
                    {
                        "drugbank-id": "DB13478",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Meptazinol"
                    },
                    {
                        "drugbank-id": "DB13605",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Phenoperidine"
                    },
                    {
                        "drugbank-id": "DB13606",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Phenazocine"
                    },
                    {
                        "drugbank-id": "DB13787",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Tilidine"
                    },
                    {
                        "drugbank-id": "DB15360",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Carfentanil C 11"
                    },
                    {
                        "drugbank-id": "DB15465",
                        "description": "The risk or severity of hypotension and CNS depression can be increased when Mesoridazine is combined with Benzhydrocodone"
                    },
                    {
                        "drugbank-id": "DB00205",
                        "description": "The risk or severity of QTc prolongation can be increased when Pyrimethamine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00250",
                        "description": "The risk or severity of QTc prolongation can be increased when Dapsone is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00613",
                        "description": "The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The risk or severity of QTc prolongation can be increased when Quinidine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01103",
                        "description": "The risk or severity of QTc prolongation can be increased when Quinacrine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01117",
                        "description": "The risk or severity of QTc prolongation can be increased when Atovaquone is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01131",
                        "description": "The risk or severity of QTc prolongation can be increased when Proguanil is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01299",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfadoxine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB06608",
                        "description": "The risk or severity of QTc prolongation can be increased when Tafenoquine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB06697",
                        "description": "The risk or severity of QTc prolongation can be increased when Artemether is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB09274",
                        "description": "The risk or severity of QTc prolongation can be increased when Artesunate is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11638",
                        "description": "The risk or severity of QTc prolongation can be increased when Artenimol is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11809",
                        "description": "The risk or severity of QTc prolongation can be increased when Artefenomel is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB12314",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorproguanil is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB12617",
                        "description": "The risk or severity of QTc prolongation can be increased when Mizoribine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB12975",
                        "description": "The risk or severity of QTc prolongation can be increased when Pyronaridine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13132",
                        "description": "The risk or severity of QTc prolongation can be increased when Artemisinin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13851",
                        "description": "The risk or severity of QTc prolongation can be increased when Artemotil is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13941",
                        "description": "The risk or severity of QTc prolongation can be increased when Piperaquine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB14066",
                        "description": "The risk or severity of QTc prolongation can be increased when Tetrandrine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB14763",
                        "description": "The risk or severity of QTc prolongation can be increased when Cycloguanil is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00190",
                        "description": "The therapeutic efficacy of Carbidopa can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00340",
                        "description": "The therapeutic efficacy of Metixene can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00376",
                        "description": "The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00387",
                        "description": "The therapeutic efficacy of Procyclidine can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00392",
                        "description": "The therapeutic efficacy of Profenamine can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "The therapeutic efficacy of Lisuride can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00810",
                        "description": "The therapeutic efficacy of Biperiden can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01043",
                        "description": "The therapeutic efficacy of Memantine can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB02105",
                        "description": "The therapeutic efficacy of 3 5 Dinitrocatechol can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB06535",
                        "description": "The therapeutic efficacy of Etilevodopa can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB08997",
                        "description": "The therapeutic efficacy of Dexetimide can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11632",
                        "description": "The therapeutic efficacy of Opicapone can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB12478",
                        "description": "The therapeutic efficacy of Piribedil can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB12783",
                        "description": "The therapeutic efficacy of Benserazide can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13252",
                        "description": "The therapeutic efficacy of Tropatepine can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13313",
                        "description": "The therapeutic efficacy of Melevodopa can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13385",
                        "description": "The therapeutic efficacy of Dihydroergocryptine can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13413",
                        "description": "The therapeutic efficacy of Phenglutarimide can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13448",
                        "description": "The therapeutic efficacy of Mazaticol can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13468",
                        "description": "The therapeutic efficacy of Etybenzatropine can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13502",
                        "description": "The therapeutic efficacy of Budipine can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13619",
                        "description": "The therapeutic efficacy of Bornaprine can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13636",
                        "description": "The therapeutic efficacy of Etanautine can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB15130",
                        "description": "The therapeutic efficacy of Dexpramipexole can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "The therapeutic efficacy of Mesoridazine can be decreased when used in combination with Cabergoline"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "The therapeutic efficacy of Mesoridazine can be decreased when used in combination with Bromocriptine"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "The therapeutic efficacy of Mesoridazine can be decreased when used in combination with Rasagiline"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The therapeutic efficacy of Mesoridazine can be decreased when used in combination with Apomorphine"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The therapeutic efficacy of Mesoridazine can be decreased when used in combination with Amantadine"
                    },
                    {
                        "drugbank-id": "DB00323",
                        "description": "The therapeutic efficacy of Mesoridazine can be decreased when used in combination with Tolcapone"
                    },
                    {
                        "drugbank-id": "DB00494",
                        "description": "The therapeutic efficacy of Mesoridazine can be decreased when used in combination with Entacapone"
                    },
                    {
                        "drugbank-id": "DB01235",
                        "description": "The therapeutic efficacy of Levodopa can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB08954",
                        "description": "The therapeutic efficacy of Ifenprodil can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00837",
                        "description": "The therapeutic efficacy of Mesoridazine can be decreased when used in combination with Progabide"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The therapeutic efficacy of Selegiline can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB05316",
                        "description": "The therapeutic efficacy of Pimavanserin can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "The therapeutic efficacy of Mesoridazine can be decreased when used in combination with Pergolide"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The therapeutic efficacy of Mesoridazine can be decreased when used in combination with Safinamide"
                    },
                    {
                        "drugbank-id": "DB00209",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Trospium"
                    },
                    {
                        "drugbank-id": "DB00219",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Oxyphenonium"
                    },
                    {
                        "drugbank-id": "DB00332",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Ipratropium"
                    },
                    {
                        "drugbank-id": "DB00383",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Oxyphencyclimine"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Cyproheptadine"
                    },
                    {
                        "drugbank-id": "DB00462",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Methscopolamine bromide"
                    },
                    {
                        "drugbank-id": "DB00505",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Tridihexethyl"
                    },
                    {
                        "drugbank-id": "DB00517",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Anisotropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00670",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Pirenzepine"
                    },
                    {
                        "drugbank-id": "DB00725",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Homatropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00767",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Benzquinamide"
                    },
                    {
                        "drugbank-id": "DB00777",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Propiomazine"
                    },
                    {
                        "drugbank-id": "DB00782",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Propantheline"
                    },
                    {
                        "drugbank-id": "DB00804",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Dicyclomine"
                    },
                    {
                        "drugbank-id": "DB00940",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Methantheline"
                    },
                    {
                        "drugbank-id": "DB00942",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Cycrimine"
                    },
                    {
                        "drugbank-id": "DB00986",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Glycopyrronium"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Oxybutynin"
                    },
                    {
                        "drugbank-id": "DB01148",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Flavoxate"
                    },
                    {
                        "drugbank-id": "DB01231",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Diphenidol"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Tiotropium"
                    },
                    {
                        "drugbank-id": "DB01625",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Isopropamide"
                    },
                    {
                        "drugbank-id": "DB04843",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Mepenzolate"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Fesoterodine"
                    },
                    {
                        "drugbank-id": "DB06787",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Hexocyclium"
                    },
                    {
                        "drugbank-id": "DB08801",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Dimetindene"
                    },
                    {
                        "drugbank-id": "DB08897",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Aclidinium"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Umeclidinium"
                    },
                    {
                        "drugbank-id": "DB09262",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Imidafenacin"
                    },
                    {
                        "drugbank-id": "DB09300",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Butylscopolamine"
                    },
                    {
                        "drugbank-id": "DB11235",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Thonzylamine"
                    },
                    {
                        "drugbank-id": "DB11315",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Methscopolamine"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Revefenacin"
                    },
                    {
                        "drugbank-id": "DB12086",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Oxitropium"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Propiverine"
                    },
                    {
                        "drugbank-id": "DB12526",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Batefenterol"
                    },
                    {
                        "drugbank-id": "DB12554",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Mebeverine"
                    },
                    {
                        "drugbank-id": "DB13254",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Prifinium"
                    },
                    {
                        "drugbank-id": "DB13351",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Piperidolate"
                    },
                    {
                        "drugbank-id": "DB13369",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Benzilone"
                    },
                    {
                        "drugbank-id": "DB13380",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Difemerine"
                    },
                    {
                        "drugbank-id": "DB13507",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Poldine"
                    },
                    {
                        "drugbank-id": "DB13542",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Bevonium"
                    },
                    {
                        "drugbank-id": "DB13581",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Rociverine"
                    },
                    {
                        "drugbank-id": "DB13666",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Tiemonium iodide"
                    },
                    {
                        "drugbank-id": "DB13678",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Dihexyverine"
                    },
                    {
                        "drugbank-id": "DB13695",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Penthienate"
                    },
                    {
                        "drugbank-id": "DB13720",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Diphemanil"
                    },
                    {
                        "drugbank-id": "DB13738",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Camylofin"
                    },
                    {
                        "drugbank-id": "DB13759",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Fenpiverinium"
                    },
                    {
                        "drugbank-id": "DB13769",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Emetonium iodide"
                    },
                    {
                        "drugbank-id": "DB13844",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Pipenzolate"
                    },
                    {
                        "drugbank-id": "DB13850",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Timepidium"
                    },
                    {
                        "drugbank-id": "DB09007",
                        "description": "Mesoridazine may increase the central nervous system depressant CNS depressant activities of Chlorphenoxamine"
                    },
                    {
                        "drugbank-id": "DB01198",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Zopiclone"
                    },
                    {
                        "drugbank-id": "DB01370",
                        "description": "Aluminium can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01377",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01390",
                        "description": "Sodium bicarbonate can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06723",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06724",
                        "description": "Calcium carbonate can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08938",
                        "description": "Magaldrate can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09104",
                        "description": "Magnesium hydroxide can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09281",
                        "description": "Magnesium trisilicate can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09481",
                        "description": "Magnesium carbonate can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13209",
                        "description": "Bismuth subnitrate can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13249",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13280",
                        "description": "Aluminium acetoacetate can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13322",
                        "description": "Hydrotalcite can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13486",
                        "description": "Magnesium peroxide can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13595",
                        "description": "Almasilate can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13626",
                        "description": "Aluminium glycinate can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13650",
                        "description": "Aloglutamol can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13829",
                        "description": "Calcium silicate can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14517",
                        "description": "Aluminium phosphate can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00216",
                        "description": "The risk or severity of adverse effects can be increased when Eletriptan is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00315",
                        "description": "The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00514",
                        "description": "The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00579",
                        "description": "The risk or severity of adverse effects can be increased when Mazindol is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "The risk or severity of adverse effects can be increased when Sumatriptan is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "The risk or severity of adverse effects can be increased when Ergotamine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "The risk or severity of adverse effects can be increased when Almotriptan is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00952",
                        "description": "The risk or severity of adverse effects can be increased when Naratriptan is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "The risk or severity of adverse effects can be increased when Rizatriptan is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00998",
                        "description": "The risk or severity of adverse effects can be increased when Frovatriptan is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "The risk or severity of adverse effects can be increased when Ergometrine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB09194",
                        "description": "The risk or severity of adverse effects can be increased when Etoperidone is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB09195",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Lorpiprazole"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "Mesoridazine may decrease the stimulatory activities of Phentermine"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "Mesoridazine may decrease the stimulatory activities of Pseudoephedrine"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "Mesoridazine may decrease the stimulatory activities of Benzphetamine"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "Mesoridazine may decrease the stimulatory activities of Diethylpropion"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "Mesoridazine may decrease the stimulatory activities of Lisdexamfetamine"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "Mesoridazine may decrease the stimulatory activities of Mephentermine"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "Mesoridazine may decrease the stimulatory activities of MMDA"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "Mesoridazine may decrease the stimulatory activities of 2 5 Dimethoxy 4 ethylamphetamine"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "Mesoridazine may decrease the stimulatory activities of Chlorphentermine"
                    },
                    {
                        "drugbank-id": "DB01566",
                        "description": "Mesoridazine may decrease the stimulatory activities of Methylenedioxyethamphetamine"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "Mesoridazine may decrease the stimulatory activities of Dextroamphetamine"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "Mesoridazine may decrease the stimulatory activities of Metamfetamine"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "Mesoridazine may decrease the stimulatory activities of Iofetamine I 123"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "Mesoridazine may decrease the stimulatory activities of Ritobegron"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "Mesoridazine may decrease the stimulatory activities of Mephedrone"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "Mesoridazine may decrease the stimulatory activities of Methoxyphenamine"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "Mesoridazine may decrease the stimulatory activities of Gepefrine"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "Mesoridazine may decrease the stimulatory activities of 2 5 Dimethoxy 4 ethylthioamphetamine"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Dofetilide"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Clemastine"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Ibutilide"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Grepafloxacin"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Trovafloxacin"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Cocaine"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Domperidone"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Sparfloxacin"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Bepridil"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Temafloxacin"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Romidepsin"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Eliglustat"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Ribociclib"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB13074",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Macimorelin"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Terodiline"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of QTc prolongation can be increased when Citalopram is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of QTc prolongation can be increased when Thioridazine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of QTc prolongation can be increased when Flupentixol is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Iloperidone"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "The risk or severity of QTc prolongation can be increased when Goserelin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00556",
                        "description": "The risk or severity of QTc prolongation can be increased when Perflutren is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The risk or severity of QTc prolongation can be increased when Cinnarizine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "The risk or severity of QTc prolongation can be increased when Atropine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "The risk or severity of QTc prolongation can be increased when Adenosine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The risk or severity of QTc prolongation can be increased when Pentamidine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of QTc prolongation can be increased when Dolasetron is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "The risk or severity of QTc prolongation can be increased when Roxithromycin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "The risk or severity of QTc prolongation can be increased when Cinoxacin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The risk or severity of QTc prolongation can be increased when Loperamide is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of QTc prolongation can be increased when Granisetron is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Telithromycin"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Lomefloxacin"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Papaverine"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Chlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Nifedipine"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Levofloxacin"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Gemifloxacin"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Ofloxacin"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Saquinavir"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Mibefradil"
                    },
                    {
                        "drugbank-id": "DB01599",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Probucol"
                    },
                    {
                        "drugbank-id": "DB02638",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Terlipressin"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Prenylamine"
                    },
                    {
                        "drugbank-id": "DB04957",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Azimilide"
                    },
                    {
                        "drugbank-id": "DB05223",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Pracinostat"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Technetium Tc 99m ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Garenoxacin"
                    },
                    {
                        "drugbank-id": "DB06200",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Tedisamil"
                    },
                    {
                        "drugbank-id": "DB06334",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Tucidinostat"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Telavancin"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Pazopanib"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Nemonoxacin"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB08799",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Antazoline"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB08903",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Bedaquiline"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Fendiline"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Ceritinib"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Lenvatinib"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Benidipine"
                    },
                    {
                        "drugbank-id": "DB09555",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11640",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11830",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Mocetinostat"
                    },
                    {
                        "drugbank-id": "DB11841",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Entinostat"
                    },
                    {
                        "drugbank-id": "DB12174",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with CUDC 101"
                    },
                    {
                        "drugbank-id": "DB12286",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Simendan"
                    },
                    {
                        "drugbank-id": "DB12376",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Ricolinostat"
                    },
                    {
                        "drugbank-id": "DB12523",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Mizolastine"
                    },
                    {
                        "drugbank-id": "DB12565",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Abexinostat"
                    },
                    {
                        "drugbank-id": "DB12877",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Oxatomide"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Sitafloxacin"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Otilonium"
                    },
                    {
                        "drugbank-id": "DB13546",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Nizofenone"
                    },
                    {
                        "drugbank-id": "DB13652",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Bunaftine"
                    },
                    {
                        "drugbank-id": "DB13653",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Lorcainide"
                    },
                    {
                        "drugbank-id": "DB13679",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Dexchlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Dexverapamil"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Ivosidenib"
                    },
                    {
                        "drugbank-id": "DB01084",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Emedastine"
                    },
                    {
                        "drugbank-id": "DB11718",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Encorafenib"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The risk or severity of QTc prolongation can be increased when Octreotide is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00107",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "The risk or severity of QTc prolongation can be increased when Isradipine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "The risk or severity of QTc prolongation can be increased when Buclizine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The risk or severity of QTc prolongation can be increased when Digoxin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "The risk or severity of QTc prolongation can be increased when Galantamine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "The risk or severity of QTc prolongation can be increased when Losartan is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of QTc prolongation can be increased when Moexipril is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00719",
                        "description": "The risk or severity of QTc prolongation can be increased when Azatadine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The risk or severity of QTc prolongation can be increased when Indapamide is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00825",
                        "description": "The risk or severity of QTc prolongation can be increased when Levomenthol is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The risk or severity of QTc prolongation can be increased when Tacrolimus is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00920",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "The risk or severity of QTc prolongation can be increased when Famotidine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The risk or severity of QTc prolongation can be increased when Formoterol is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The risk or severity of QTc prolongation can be increased when Felodipine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The risk or severity of QTc prolongation can be increased when Promethazine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01228",
                        "description": "The risk or severity of QTc prolongation can be increased when Encainide is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01426",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01620",
                        "description": "The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB04695",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB05465",
                        "description": "The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB06217",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB06468",
                        "description": "The risk or severity of QTc prolongation can be increased when Cariporide is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB06699",
                        "description": "The risk or severity of QTc prolongation can be increased when Degarelix is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB06719",
                        "description": "The risk or severity of QTc prolongation can be increased when Buserelin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB06788",
                        "description": "The risk or severity of QTc prolongation can be increased when Histrelin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB06825",
                        "description": "The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB07780",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of QTc prolongation can be increased when Eribulin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB08936",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The risk or severity of QTc prolongation can be increased when Flumequine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "The risk or severity of QTc prolongation can be increased when Efonidipine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The risk or severity of QTc prolongation can be increased when Niguldipine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11390",
                        "description": "The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11397",
                        "description": "The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11408",
                        "description": "The risk or severity of QTc prolongation can be increased when Famphur is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11412",
                        "description": "The risk or severity of QTc prolongation can be increased when Fenthion is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11448",
                        "description": "The risk or severity of QTc prolongation can be increased when Phosmet is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11591",
                        "description": "The risk or severity of QTc prolongation can be increased when Bilastine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11614",
                        "description": "The risk or severity of QTc prolongation can be increased when Rupatadine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The risk or severity of QTc prolongation can be increased when Ebastine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11891",
                        "description": "The risk or severity of QTc prolongation can be increased when CUDC 907 is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB12231",
                        "description": "The risk or severity of QTc prolongation can be increased when Temefos is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The risk or severity of QTc prolongation can be increased when Triclabendazole is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB12645",
                        "description": "The risk or severity of QTc prolongation can be increased when Givinostat is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB12712",
                        "description": "The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13358",
                        "description": "The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13555",
                        "description": "The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13651",
                        "description": "The risk or severity of QTc prolongation can be increased when Lorajmine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The risk or severity of QTc prolongation can be increased when Acetyldigoxin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13744",
                        "description": "The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "The risk or severity of QTc prolongation can be increased when Inotersen is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11853",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "The metabolism of Metoprolol can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Quinine"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Chloroquine"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Primaquine"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Lumefantrine"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The metabolism of Terfenadine can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The metabolism of Nilotinib can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Nicardipine"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Fluvoxamine"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Venlafaxine"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Clobazam"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Clozapine"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Imipramine"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Duloxetine"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Chlorpromazine"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Tranylcypromine"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The metabolism of Desipramine can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "The metabolism of Vilazodone can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The metabolism of Dosulepin can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "The metabolism of Ritanserin can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Cyclosporine"
                    },
                    {
                        "drugbank-id": "DB00169",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Cholecalciferol"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Celecoxib"
                    },
                    {
                        "drugbank-id": "DB00496",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Darifenacin"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Cimetidine"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00705",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Delavirdine"
                    },
                    {
                        "drugbank-id": "DB00857",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Terbinafine"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Tipranavir"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Ketoconazole"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Perhexiline"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Tegaserod"
                    },
                    {
                        "drugbank-id": "DB02703",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Fusidic acid"
                    },
                    {
                        "drugbank-id": "DB05812",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Abiraterone"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Panobinostat"
                    },
                    {
                        "drugbank-id": "DB06729",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Sulfaphenazole"
                    },
                    {
                        "drugbank-id": "DB06819",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Phenylbutyric acid"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Manidipine"
                    },
                    {
                        "drugbank-id": "DB09291",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Rolapitant"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Asunaprevir"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Rucaparib"
                    },
                    {
                        "drugbank-id": "DB13174",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Rhein"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "The metabolism of Lorcaserin can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Berotralstat"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Paroxetine"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "The metabolism of Bupropion can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Cisapride"
                    },
                    {
                        "drugbank-id": "DB01012",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Cinacalcet"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Propafenone"
                    },
                    {
                        "drugbank-id": "DB06595",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Midostaurin"
                    },
                    {
                        "drugbank-id": "DB08909",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Glycerol phenylbutyrate"
                    },
                    {
                        "drugbank-id": "DB00042",
                        "description": "The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00083",
                        "description": "The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "The risk or severity of adverse effects can be increased when Baclofen is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00189",
                        "description": "The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00202",
                        "description": "The risk or severity of adverse effects can be increased when Succinylcholine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00228",
                        "description": "The risk or severity of adverse effects can be increased when Enflurane is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00237",
                        "description": "The risk or severity of adverse effects can be increased when Butabarbital is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00241",
                        "description": "The risk or severity of adverse effects can be increased when Butalbital is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "The risk or severity of adverse effects can be increased when Methysergide is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "The risk or severity of adverse effects can be increased when Topiramate is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The risk or severity of adverse effects can be increased when Atomoxetine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "The risk or severity of adverse effects can be increased when Etomidate is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00306",
                        "description": "The risk or severity of adverse effects can be increased when Talbutal is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "The risk or severity of adverse effects can be increased when Pentobarbital is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of adverse effects can be increased when Cetirizine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of adverse effects can be increased when Trimethadione is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "The risk or severity of adverse effects can be increased when Thiethylperazine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00377",
                        "description": "The risk or severity of adverse effects can be increased when Palonosetron is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00416",
                        "description": "The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "The risk or severity of adverse effects can be increased when Secobarbital is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00423",
                        "description": "The risk or severity of adverse effects can be increased when Methocarbamol is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of adverse effects can be increased when Triprolidine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00463",
                        "description": "The risk or severity of adverse effects can be increased when Metharbital is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00474",
                        "description": "The risk or severity of adverse effects can be increased when Methohexital is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00483",
                        "description": "The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00565",
                        "description": "The risk or severity of adverse effects can be increased when Cisatracurium is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of adverse effects can be increased when Ethosuximide is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00617",
                        "description": "The risk or severity of adverse effects can be increased when Paramethadione is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The risk or severity of adverse effects can be increased when Efavirenz is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00645",
                        "description": "The risk or severity of adverse effects can be increased when Dyclonine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00660",
                        "description": "The risk or severity of adverse effects can be increased when Metaxalone is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00662",
                        "description": "The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of adverse effects can be increased when Moricizine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of adverse effects can be increased when Tizanidine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00728",
                        "description": "The risk or severity of adverse effects can be increased when Rocuronium is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00732",
                        "description": "The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00737",
                        "description": "The risk or severity of adverse effects can be increased when Meclizine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00740",
                        "description": "The risk or severity of adverse effects can be increased when Riluzole is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00747",
                        "description": "The risk or severity of adverse effects can be increased when Scopolamine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of adverse effects can be increased when Isoflurane is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00754",
                        "description": "The risk or severity of adverse effects can be increased when Ethotoin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00771",
                        "description": "The risk or severity of adverse effects can be increased when Clidinium is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00776",
                        "description": "The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The risk or severity of adverse effects can be increased when Primidone is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of adverse effects can be increased when Propofol is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "The risk or severity of adverse effects can be increased when Acetazolamide is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00832",
                        "description": "The risk or severity of adverse effects can be increased when Phensuximide is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of adverse effects can be increased when Brompheniramine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00843",
                        "description": "The risk or severity of adverse effects can be increased when Donepezil is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00906",
                        "description": "The risk or severity of adverse effects can be increased when Tiagabine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The risk or severity of adverse effects can be increased when Zonisamide is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00941",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Hexafluronium"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Felbamate"
                    },
                    {
                        "drugbank-id": "DB00962",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Zaleplon"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Desloratadine"
                    },
                    {
                        "drugbank-id": "DB00969",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Alosetron"
                    },
                    {
                        "drugbank-id": "DB00980",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Ramelteon"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Dimenhydrinate"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Guanfacine"
                    },
                    {
                        "drugbank-id": "DB01028",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Methoxyflurane"
                    },
                    {
                        "drugbank-id": "DB01063",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Acetophenazine"
                    },
                    {
                        "drugbank-id": "DB01065",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Melatonin"
                    },
                    {
                        "drugbank-id": "DB01068",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Clonazepam"
                    },
                    {
                        "drugbank-id": "DB01080",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Vigabatrin"
                    },
                    {
                        "drugbank-id": "DB01107",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Methyprylon"
                    },
                    {
                        "drugbank-id": "DB01121",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Phenacemide"
                    },
                    {
                        "drugbank-id": "DB01135",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Doxacurium"
                    },
                    {
                        "drugbank-id": "DB01154",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Thiamylal"
                    },
                    {
                        "drugbank-id": "DB01159",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Halothane"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Phenobarbital"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Cyclizine"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Desflurane"
                    },
                    {
                        "drugbank-id": "DB01199",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Tubocurarine"
                    },
                    {
                        "drugbank-id": "DB01202",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Levetiracetam"
                    },
                    {
                        "drugbank-id": "DB01219",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Dantrolene"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Ketamine"
                    },
                    {
                        "drugbank-id": "DB01226",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Mivacurium"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Sevoflurane"
                    },
                    {
                        "drugbank-id": "DB01245",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Decamethonium"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Alimemazine"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with St John s Wort"
                    },
                    {
                        "drugbank-id": "DB01336",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Metocurine"
                    },
                    {
                        "drugbank-id": "DB01337",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Pancuronium"
                    },
                    {
                        "drugbank-id": "DB01338",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Pipecuronium"
                    },
                    {
                        "drugbank-id": "DB01339",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Vecuronium"
                    },
                    {
                        "drugbank-id": "DB01351",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Amobarbital"
                    },
                    {
                        "drugbank-id": "DB01352",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Aprobarbital"
                    },
                    {
                        "drugbank-id": "DB01353",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Butobarbital"
                    },
                    {
                        "drugbank-id": "DB01354",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Heptabarbital"
                    },
                    {
                        "drugbank-id": "DB01355",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Hexobarbital"
                    },
                    {
                        "drugbank-id": "DB01392",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Yohimbine"
                    },
                    {
                        "drugbank-id": "DB01437",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Glutethimide"
                    },
                    {
                        "drugbank-id": "DB01440",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with gamma Hydroxybutyric acid"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Barbital"
                    },
                    {
                        "drugbank-id": "DB01489",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Camazepam"
                    },
                    {
                        "drugbank-id": "DB01495",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Dichloralphenazone"
                    },
                    {
                        "drugbank-id": "DB01501",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Difenoxin"
                    },
                    {
                        "drugbank-id": "DB01511",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Delorazepam"
                    },
                    {
                        "drugbank-id": "DB01534",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Chlorhexadol"
                    },
                    {
                        "drugbank-id": "DB01547",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Drotebanol"
                    },
                    {
                        "drugbank-id": "DB01553",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Cloxazolam"
                    },
                    {
                        "drugbank-id": "DB01559",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Clotiazepam"
                    },
                    {
                        "drugbank-id": "DB01563",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Chloral hydrate"
                    },
                    {
                        "drugbank-id": "DB01589",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Quazepam"
                    },
                    {
                        "drugbank-id": "DB01594",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Cinolazepam"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Periciazine"
                    },
                    {
                        "drugbank-id": "DB01616",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Alverine"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Pipotiazine"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Thioproperazine"
                    },
                    {
                        "drugbank-id": "DB02234",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with S Ethylisothiourea"
                    },
                    {
                        "drugbank-id": "DB02852",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Domoic Acid"
                    },
                    {
                        "drugbank-id": "DB04165",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Valpromide"
                    },
                    {
                        "drugbank-id": "DB04819",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Methapyrilene"
                    },
                    {
                        "drugbank-id": "DB04821",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Nomifensine"
                    },
                    {
                        "drugbank-id": "DB04827",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Urethane"
                    },
                    {
                        "drugbank-id": "DB04833",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Methaqualone"
                    },
                    {
                        "drugbank-id": "DB04834",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Flunarizine"
                    },
                    {
                        "drugbank-id": "DB04885",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Cilansetron"
                    },
                    {
                        "drugbank-id": "DB04888",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Bifeprunox"
                    },
                    {
                        "drugbank-id": "DB04903",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Pagoclone"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Flibanserin"
                    },
                    {
                        "drugbank-id": "DB04917",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Renzapride"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Ezogabine"
                    },
                    {
                        "drugbank-id": "DB05227",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with APD791"
                    },
                    {
                        "drugbank-id": "DB05232",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Tetrodotoxin"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Methsuximide"
                    },
                    {
                        "drugbank-id": "DB05541",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Brivaracetam"
                    },
                    {
                        "drugbank-id": "DB05542",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Naronapride"
                    },
                    {
                        "drugbank-id": "DB05562",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Naluzotan"
                    },
                    {
                        "drugbank-id": "DB05607",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with PRX 08066"
                    },
                    {
                        "drugbank-id": "DB05687",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with BL 1020"
                    },
                    {
                        "drugbank-id": "DB05710",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Gantacurium"
                    },
                    {
                        "drugbank-id": "DB06077",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Lumateperone"
                    },
                    {
                        "drugbank-id": "DB06109",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with YKP 1358"
                    },
                    {
                        "drugbank-id": "DB06218",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Lacosamide"
                    },
                    {
                        "drugbank-id": "DB06264",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Tolperisone"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Levocetirizine"
                    },
                    {
                        "drugbank-id": "DB06446",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Dotarizine"
                    },
                    {
                        "drugbank-id": "DB06458",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Remacemide"
                    },
                    {
                        "drugbank-id": "DB06470",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Clomethiazole"
                    },
                    {
                        "drugbank-id": "DB06527",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Tramiprosate"
                    },
                    {
                        "drugbank-id": "DB06529",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Ocinaplon"
                    },
                    {
                        "drugbank-id": "DB06554",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Gaboxadol"
                    },
                    {
                        "drugbank-id": "DB06594",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Agomelatine"
                    },
                    {
                        "drugbank-id": "DB06660",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Saredutant"
                    },
                    {
                        "drugbank-id": "DB06690",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Nitrous oxide"
                    },
                    {
                        "drugbank-id": "DB06716",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Fospropofol"
                    },
                    {
                        "drugbank-id": "DB06753",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Triclofos"
                    },
                    {
                        "drugbank-id": "DB06770",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Benzyl alcohol"
                    },
                    {
                        "drugbank-id": "DB06797",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Mebutamate"
                    },
                    {
                        "drugbank-id": "DB08059",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Wortmannin"
                    },
                    {
                        "drugbank-id": "DB08329",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Sulthiame"
                    },
                    {
                        "drugbank-id": "DB08810",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Cinitapride"
                    },
                    {
                        "drugbank-id": "DB08839",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Serotonin"
                    },
                    {
                        "drugbank-id": "DB08872",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Gabapentin enacarbil"
                    },
                    {
                        "drugbank-id": "DB08892",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Arbaclofen Placarbil"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Hexamethonium"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Eperisone"
                    },
                    {
                        "drugbank-id": "DB09000",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Cyamemazine"
                    },
                    {
                        "drugbank-id": "DB09001",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Barbexaclone"
                    },
                    {
                        "drugbank-id": "DB09011",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Beclamide"
                    },
                    {
                        "drugbank-id": "DB09014",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Captodiame"
                    },
                    {
                        "drugbank-id": "DB09017",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Brotizolam"
                    },
                    {
                        "drugbank-id": "DB09021",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Benzoctamine"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Tasimelteon"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Stiripentol"
                    },
                    {
                        "drugbank-id": "DB09119",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Eslicarbazepine acetate"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Brexpiprazole"
                    },
                    {
                        "drugbank-id": "DB09184",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Edivoxetine"
                    },
                    {
                        "drugbank-id": "DB09186",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Nisoxetine"
                    },
                    {
                        "drugbank-id": "DB09187",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Lortalamine"
                    },
                    {
                        "drugbank-id": "DB09190",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Talopram"
                    },
                    {
                        "drugbank-id": "DB09223",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Blonanserin"
                    },
                    {
                        "drugbank-id": "DB09247",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Iproclozide"
                    },
                    {
                        "drugbank-id": "DB09290",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Ramosetron"
                    },
                    {
                        "drugbank-id": "DB11156",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Pyrantel"
                    },
                    {
                        "drugbank-id": "DB11371",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Alfaxalone"
                    },
                    {
                        "drugbank-id": "DB11400",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Doramectin"
                    },
                    {
                        "drugbank-id": "DB11428",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Medetomidine"
                    },
                    {
                        "drugbank-id": "DB11477",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Xylazine"
                    },
                    {
                        "drugbank-id": "DB11540",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Propiopromazine"
                    },
                    {
                        "drugbank-id": "DB11543",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Romifidine"
                    },
                    {
                        "drugbank-id": "DB11549",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Tiletamine"
                    },
                    {
                        "drugbank-id": "DB11552",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Tricaine"
                    },
                    {
                        "drugbank-id": "DB11556",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Detomidine"
                    },
                    {
                        "drugbank-id": "DB11582",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Thiocolchicoside"
                    },
                    {
                        "drugbank-id": "DB11675",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Mosapride"
                    },
                    {
                        "drugbank-id": "DB11686",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Iferanserin"
                    },
                    {
                        "drugbank-id": "DB11699",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Tropisetron"
                    },
                    {
                        "drugbank-id": "DB11755",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11859",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Brexanolone"
                    },
                    {
                        "drugbank-id": "DB11868",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Etiracetam"
                    },
                    {
                        "drugbank-id": "DB11889",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Lanicemine"
                    },
                    {
                        "drugbank-id": "DB11957",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Idalopirdine"
                    },
                    {
                        "drugbank-id": "DB12071",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Vabicaserin"
                    },
                    {
                        "drugbank-id": "DB12105",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Imagabalin"
                    },
                    {
                        "drugbank-id": "DB12110",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with m Chlorophenylpiperazine"
                    },
                    {
                        "drugbank-id": "DB12111",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with MK 212"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Vinpocetine"
                    },
                    {
                        "drugbank-id": "DB12163",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Sarpogrelate"
                    },
                    {
                        "drugbank-id": "DB12177",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Eplivanserin"
                    },
                    {
                        "drugbank-id": "DB12229",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Cerlapirdine"
                    },
                    {
                        "drugbank-id": "DB12308",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Eltanolone"
                    },
                    {
                        "drugbank-id": "DB12338",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Carisbamate"
                    },
                    {
                        "drugbank-id": "DB12361",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Piclozotan"
                    },
                    {
                        "drugbank-id": "DB12395",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Esreboxetine"
                    },
                    {
                        "drugbank-id": "DB12427",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Orvepitant"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Ketanserin"
                    },
                    {
                        "drugbank-id": "DB12537",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Benzodiazepine"
                    },
                    {
                        "drugbank-id": "DB12576",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with AZD 3043"
                    },
                    {
                        "drugbank-id": "DB12590",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Indiplon"
                    },
                    {
                        "drugbank-id": "DB12661",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Urapidil"
                    },
                    {
                        "drugbank-id": "DB12725",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with TD 8954"
                    },
                    {
                        "drugbank-id": "DB12883",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Eltoprazine"
                    },
                    {
                        "drugbank-id": "DB12951",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Pivagabine"
                    },
                    {
                        "drugbank-id": "DB12958",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Prothipendyl"
                    },
                    {
                        "drugbank-id": "DB12989",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Neosaxitoxin"
                    },
                    {
                        "drugbank-id": "DB13099",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Valnoctamide"
                    },
                    {
                        "drugbank-id": "DB13213",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Butaperazine"
                    },
                    {
                        "drugbank-id": "DB13219",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Medifoxamine"
                    },
                    {
                        "drugbank-id": "DB13221",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Apronalide"
                    },
                    {
                        "drugbank-id": "DB13234",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Propanidid"
                    },
                    {
                        "drugbank-id": "DB13253",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Proxibarbal"
                    },
                    {
                        "drugbank-id": "DB13295",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Atracurium"
                    },
                    {
                        "drugbank-id": "DB13303",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Febarbamate"
                    },
                    {
                        "drugbank-id": "DB13323",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Trichloroethylene"
                    },
                    {
                        "drugbank-id": "DB13324",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Tetrazepam"
                    },
                    {
                        "drugbank-id": "DB13331",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Pyrithyldione"
                    },
                    {
                        "drugbank-id": "DB13354",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Phenprobamate"
                    },
                    {
                        "drugbank-id": "DB13357",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Styramate"
                    },
                    {
                        "drugbank-id": "DB13362",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Pheneturide"
                    },
                    {
                        "drugbank-id": "DB13370",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Bromisoval"
                    },
                    {
                        "drugbank-id": "DB13377",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Vinbarbital"
                    },
                    {
                        "drugbank-id": "DB13382",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Chlorproethazine"
                    },
                    {
                        "drugbank-id": "DB13396",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Neocitrullamon"
                    },
                    {
                        "drugbank-id": "DB13402",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Acetylglycinamide chloral hydrate"
                    },
                    {
                        "drugbank-id": "DB13403",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Oxypertine"
                    },
                    {
                        "drugbank-id": "DB13414",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Fenyramidol"
                    },
                    {
                        "drugbank-id": "DB13420",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Thiazinam"
                    },
                    {
                        "drugbank-id": "DB13457",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Oxaflozane"
                    },
                    {
                        "drugbank-id": "DB13505",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Emepronium"
                    },
                    {
                        "drugbank-id": "DB13534",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Gedocarnil"
                    },
                    {
                        "drugbank-id": "DB13541",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Iprazochrome"
                    },
                    {
                        "drugbank-id": "DB13554",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Moperone"
                    },
                    {
                        "drugbank-id": "DB13557",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Thiopropazate"
                    },
                    {
                        "drugbank-id": "DB13572",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Emylcamate"
                    },
                    {
                        "drugbank-id": "DB13577",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Allobarbital"
                    },
                    {
                        "drugbank-id": "DB13584",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Gallamine"
                    },
                    {
                        "drugbank-id": "DB13588",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Naftidrofuryl"
                    },
                    {
                        "drugbank-id": "DB13598",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Diethyl ether"
                    },
                    {
                        "drugbank-id": "DB13623",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Fabomotizole"
                    },
                    {
                        "drugbank-id": "DB13642",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Pridinol"
                    },
                    {
                        "drugbank-id": "DB13648",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Alcuronium"
                    },
                    {
                        "drugbank-id": "DB13662",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Hexapropymate"
                    },
                    {
                        "drugbank-id": "DB13676",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Mosapramine"
                    },
                    {
                        "drugbank-id": "DB13687",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Niaprazine"
                    },
                    {
                        "drugbank-id": "DB13690",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Vinyl ether"
                    },
                    {
                        "drugbank-id": "DB13733",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Methylpentynol"
                    },
                    {
                        "drugbank-id": "DB13737",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Cyclobarbital"
                    },
                    {
                        "drugbank-id": "DB13745",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Fazadinium bromide"
                    },
                    {
                        "drugbank-id": "DB13754",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Mephenoxalone"
                    },
                    {
                        "drugbank-id": "DB13770",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Vinylbital"
                    },
                    {
                        "drugbank-id": "DB13799",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Ethadione"
                    },
                    {
                        "drugbank-id": "DB13805",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Reposal"
                    },
                    {
                        "drugbank-id": "DB13817",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Carbromal"
                    },
                    {
                        "drugbank-id": "DB13837",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Doxefazepam"
                    },
                    {
                        "drugbank-id": "DB13872",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Lormetazepam"
                    },
                    {
                        "drugbank-id": "DB13948",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with N 2 hydroxybenzyl 2 5 dimethoxy 4 cyanophenylethylamine"
                    },
                    {
                        "drugbank-id": "DB13984",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Cyclopropane"
                    },
                    {
                        "drugbank-id": "DB13993",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with MRK 409"
                    },
                    {
                        "drugbank-id": "DB14010",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with 5 methoxy N N dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB14050",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Cannabidivarin"
                    },
                    {
                        "drugbank-id": "DB14575",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Eslicarbazepine"
                    },
                    {
                        "drugbank-id": "DB14651",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Perphenazine enanthate"
                    },
                    {
                        "drugbank-id": "DB14672",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Oxazepam acetate"
                    },
                    {
                        "drugbank-id": "DB14715",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Cinazepam"
                    },
                    {
                        "drugbank-id": "DB14718",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Pyrazolam"
                    },
                    {
                        "drugbank-id": "DB14719",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Bentazepam"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Solriamfetol"
                    },
                    {
                        "drugbank-id": "DB15203",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with JNJ 26489112"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB11951",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Lemborexant"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The risk or severity of adverse effects can be increased when Meperidine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "The risk or severity of adverse effects can be increased when Mephenytoin is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB12404",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Remimazolam"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The therapeutic efficacy of Mesoridazine can be increased when used in combination with Pregabalin"
                    },
                    {
                        "drugbank-id": "DB00150",
                        "description": "The risk or severity of adverse effects can be increased when Tryptophan is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "The risk or severity of adverse effects can be increased when Lorazepam is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The risk or severity of adverse effects can be increased when Reserpine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00231",
                        "description": "The risk or severity of adverse effects can be increased when Temazepam is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00234",
                        "description": "The risk or severity of adverse effects can be increased when Reboxetine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The risk or severity of adverse effects can be increased when Olanzapine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00371",
                        "description": "The risk or severity of adverse effects can be increased when Meprobamate is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "The risk or severity of adverse effects can be increased when Alprazolam is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "The risk or severity of adverse effects can be increased when Loxapine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00409",
                        "description": "The risk or severity of adverse effects can be increased when Remoxipride is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of adverse effects can be increased when Promazine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00475",
                        "description": "The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "The risk or severity of adverse effects can be increased when Triflupromazine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00546",
                        "description": "The risk or severity of adverse effects can be increased when Adinazolam is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The risk or severity of adverse effects can be increased when Lamotrigine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The risk or severity of adverse effects can be increased when Carbamazepine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "The risk or severity of adverse effects can be increased when Fluphenazine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00628",
                        "description": "The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "The risk or severity of adverse effects can be increased when Midazolam is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00690",
                        "description": "The risk or severity of adverse effects can be increased when Flurazepam is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The risk or severity of adverse effects can be increased when Risperidone is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00801",
                        "description": "The risk or severity of adverse effects can be increased when Halazepam is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "The risk or severity of adverse effects can be increased when Diazepam is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00842",
                        "description": "The risk or severity of adverse effects can be increased when Oxazepam is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "The risk or severity of adverse effects can be increased when Perphenazine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "The risk or severity of adverse effects can be increased when Triazolam is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00996",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Gabapentin"
                    },
                    {
                        "drugbank-id": "DB01178",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Chlormezanone"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Estazolam"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Quetiapine"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Aripiprazole"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Chlorprothixene"
                    },
                    {
                        "drugbank-id": "DB01445",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Bufotenine"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Midomafetamine"
                    },
                    {
                        "drugbank-id": "DB01463",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Fencamfamin"
                    },
                    {
                        "drugbank-id": "DB01472",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with 4 Methoxyamphetamine"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with 4 Bromo 2 5 dimethoxyamphetamine"
                    },
                    {
                        "drugbank-id": "DB01488",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Tenamfetamine"
                    },
                    {
                        "drugbank-id": "DB01544",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Flunitrazepam"
                    },
                    {
                        "drugbank-id": "DB01545",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Ethyl loflazepate"
                    },
                    {
                        "drugbank-id": "DB01558",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Bromazepam"
                    },
                    {
                        "drugbank-id": "DB01560",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Cathinone"
                    },
                    {
                        "drugbank-id": "DB01567",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Fludiazepam"
                    },
                    {
                        "drugbank-id": "DB01587",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Ketazolam"
                    },
                    {
                        "drugbank-id": "DB01588",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Prazepam"
                    },
                    {
                        "drugbank-id": "DB01595",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Nitrazepam"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Acepromazine"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Aceprometazine"
                    },
                    {
                        "drugbank-id": "DB01618",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Molindone"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Thiothixene"
                    },
                    {
                        "drugbank-id": "DB01954",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Rolipram"
                    },
                    {
                        "drugbank-id": "DB02207",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with 7 Nitroindazole"
                    },
                    {
                        "drugbank-id": "DB02959",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Oxitriptan"
                    },
                    {
                        "drugbank-id": "DB03575",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Phencyclidine"
                    },
                    {
                        "drugbank-id": "DB04325",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Phenethylamine"
                    },
                    {
                        "drugbank-id": "DB04599",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Aniracetam"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Lysergic acid diethylamide"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB04872",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Osanetant"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Cariprazine"
                    },
                    {
                        "drugbank-id": "DB06144",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Sertindole"
                    },
                    {
                        "drugbank-id": "DB06148",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Mianserin"
                    },
                    {
                        "drugbank-id": "DB06153",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Pizotifen"
                    },
                    {
                        "drugbank-id": "DB06512",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Deramciclane"
                    },
                    {
                        "drugbank-id": "DB06579",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Adipiplon"
                    },
                    {
                        "drugbank-id": "DB06582",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Dextofisopam"
                    },
                    {
                        "drugbank-id": "DB06678",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Esmirtazapine"
                    },
                    {
                        "drugbank-id": "DB08811",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Tofisopam"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Lurasidone"
                    },
                    {
                        "drugbank-id": "DB08922",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Perospirone"
                    },
                    {
                        "drugbank-id": "DB08927",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Amperozide"
                    },
                    {
                        "drugbank-id": "DB08986",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Etifoxine"
                    },
                    {
                        "drugbank-id": "DB09023",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Benactyzine"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Vortioxetine"
                    },
                    {
                        "drugbank-id": "DB09166",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Etizolam"
                    },
                    {
                        "drugbank-id": "DB09185",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Viloxazine"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Melperone"
                    },
                    {
                        "drugbank-id": "DB09225",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Zotepine"
                    },
                    {
                        "drugbank-id": "DB09226",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Brilaroxazine"
                    },
                    {
                        "drugbank-id": "DB09286",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Pipamperone"
                    },
                    {
                        "drugbank-id": "DB11376",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Azaperone"
                    },
                    {
                        "drugbank-id": "DB11555",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Zolazepam"
                    },
                    {
                        "drugbank-id": "DB11664",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Psilocybin"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB12184",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Gepirone"
                    },
                    {
                        "drugbank-id": "DB12273",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Ecopipam"
                    },
                    {
                        "drugbank-id": "DB12327",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Salvinorin A"
                    },
                    {
                        "drugbank-id": "DB12401",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Bromperidol"
                    },
                    {
                        "drugbank-id": "DB12518",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Raclopride"
                    },
                    {
                        "drugbank-id": "DB12710",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Perazine"
                    },
                    {
                        "drugbank-id": "DB12833",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Tandospirone"
                    },
                    {
                        "drugbank-id": "DB12867",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Benperidol"
                    },
                    {
                        "drugbank-id": "DB13014",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Hypericin"
                    },
                    {
                        "drugbank-id": "DB13025",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Tiapride"
                    },
                    {
                        "drugbank-id": "DB13082",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Nefiracetam"
                    },
                    {
                        "drugbank-id": "DB13256",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Clothiapine"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13335",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Pinazepam"
                    },
                    {
                        "drugbank-id": "DB13352",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Deanol"
                    },
                    {
                        "drugbank-id": "DB13437",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Medazepam"
                    },
                    {
                        "drugbank-id": "DB13455",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Phenibut"
                    },
                    {
                        "drugbank-id": "DB13522",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Mebicar"
                    },
                    {
                        "drugbank-id": "DB13523",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Veralipride"
                    },
                    {
                        "drugbank-id": "DB13550",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Bifemelane"
                    },
                    {
                        "drugbank-id": "DB13552",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Trifluperidol"
                    },
                    {
                        "drugbank-id": "DB13601",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Oxiracetam"
                    },
                    {
                        "drugbank-id": "DB13643",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Loprazolam"
                    },
                    {
                        "drugbank-id": "DB13665",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Fluanisone"
                    },
                    {
                        "drugbank-id": "DB13784",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Dixyrazine"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Penfluridol"
                    },
                    {
                        "drugbank-id": "DB13841",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Clopenthixol"
                    },
                    {
                        "drugbank-id": "DB14028",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Nordazepam"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Aripiprazole lauroxil"
                    },
                    {
                        "drugbank-id": "DB14509",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Lithium carbonate"
                    },
                    {
                        "drugbank-id": "DB11637",
                        "description": "Mesoridazine may increase the QTc prolonging activities of Delamanid"
                    },
                    {
                        "drugbank-id": "DB04844",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Tetrabenazine"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Deutetrabenazine"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The therapeutic efficacy of Mesoridazine can be increased when used in combination with Lofexidine"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Ticlopidine"
                    },
                    {
                        "drugbank-id": "DB00281",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Lidocaine"
                    },
                    {
                        "drugbank-id": "DB00412",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Rosiglitazone"
                    },
                    {
                        "drugbank-id": "DB00439",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Cerivastatin"
                    },
                    {
                        "drugbank-id": "DB00574",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Fenfluramine"
                    },
                    {
                        "drugbank-id": "DB00792",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Tripelennamine"
                    },
                    {
                        "drugbank-id": "DB00863",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Ranitidine"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Doxorubicin"
                    },
                    {
                        "drugbank-id": "DB01005",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Hydroxyurea"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Diphenhydramine"
                    },
                    {
                        "drugbank-id": "DB01110",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Miconazole"
                    },
                    {
                        "drugbank-id": "DB01128",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Bicalutamide"
                    },
                    {
                        "drugbank-id": "DB06370",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Indisulam"
                    },
                    {
                        "drugbank-id": "DB06412",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Oxymetholone"
                    },
                    {
                        "drugbank-id": "DB06727",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Sparteine"
                    },
                    {
                        "drugbank-id": "DB09049",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Naloxegol"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Isavuconazole"
                    },
                    {
                        "drugbank-id": "DB11753",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Rifamycin"
                    },
                    {
                        "drugbank-id": "DB11994",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Diacerein"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Levosalbutamol"
                    },
                    {
                        "drugbank-id": "DB13975",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Black cohosh"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Methimazole"
                    },
                    {
                        "drugbank-id": "DB01093",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Dimethyl sulfoxide"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Nelfinavir"
                    },
                    {
                        "drugbank-id": "DB01096",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Oxamniquine"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Lercanidipine"
                    },
                    {
                        "drugbank-id": "DB01562",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with 1 2 Phenylethyl 4 phenyl 4 acetoxypiperidine"
                    },
                    {
                        "drugbank-id": "DB14009",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Medical Cannabis"
                    },
                    {
                        "drugbank-id": "DB14635",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Curcumin sulfate"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Everolimus"
                    },
                    {
                        "drugbank-id": "DB00627",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Niacin"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Verapamil"
                    },
                    {
                        "drugbank-id": "DB12500",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Fedratinib"
                    },
                    {
                        "drugbank-id": "DB00022",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Peginterferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB00227",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Lovastatin"
                    },
                    {
                        "drugbank-id": "DB00238",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Nevirapine"
                    },
                    {
                        "drugbank-id": "DB00317",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Gefitinib"
                    },
                    {
                        "drugbank-id": "DB00338",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Omeprazole"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Vinorelbine"
                    },
                    {
                        "drugbank-id": "DB00448",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Lansoprazole"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Vinblastine"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Rabeprazole"
                    },
                    {
                        "drugbank-id": "DB01191",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Dexfenfluramine"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Etoricoxib"
                    },
                    {
                        "drugbank-id": "DB04938",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Ospemifene"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Temsirolimus"
                    },
                    {
                        "drugbank-id": "DB09065",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Cobicistat"
                    },
                    {
                        "drugbank-id": "DB11837",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Osilodrostat"
                    },
                    {
                        "drugbank-id": "DB04911",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Oritavancin"
                    },
                    {
                        "drugbank-id": "DB00184",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Nicotine"
                    },
                    {
                        "drugbank-id": "DB00185",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Cevimeline"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Sildenafil"
                    },
                    {
                        "drugbank-id": "DB00297",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Bupivacaine"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Acetaminophen"
                    },
                    {
                        "drugbank-id": "DB00379",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Mexiletine"
                    },
                    {
                        "drugbank-id": "DB00396",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Progesterone"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Buspirone"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Doxazosin"
                    },
                    {
                        "drugbank-id": "DB00592",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Piperazine"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Simvastatin"
                    },
                    {
                        "drugbank-id": "DB00699",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Nicergoline"
                    },
                    {
                        "drugbank-id": "DB00701",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Amprenavir"
                    },
                    {
                        "drugbank-id": "DB00706",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Tamsulosin"
                    },
                    {
                        "drugbank-id": "DB00731",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Nateglinide"
                    },
                    {
                        "drugbank-id": "DB00914",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Phenformin"
                    },
                    {
                        "drugbank-id": "DB01095",
                        "description": "The metabolism of Fluvastatin can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01177",
                        "description": "The metabolism of Idarubicin can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "The metabolism of Aminophenazone can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01429",
                        "description": "The metabolism of Aprindine can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB03783",
                        "description": "The metabolism of Phenacetin can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB04840",
                        "description": "The metabolism of Debrisoquine can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB04905",
                        "description": "The metabolism of Tesmilifene can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "The metabolism of Clevidipine can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB06203",
                        "description": "The metabolism of Alogliptin can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "The metabolism of Dapagliflozin can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB06735",
                        "description": "The metabolism of Enclomiphene can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB09048",
                        "description": "The metabolism of Netupitant can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The metabolism of Ibrutinib can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB09183",
                        "description": "The metabolism of Dasabuvir can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The metabolism of Propacetamol can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11915",
                        "description": "The metabolism of Valbenazine can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11979",
                        "description": "The metabolism of Elagolix can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB12070",
                        "description": "The metabolism of Letermovir can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13293",
                        "description": "The metabolism of Ipecac can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB06506",
                        "description": "The metabolism of Repinotan can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB09173",
                        "description": "The metabolism of Butyrfentanyl can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11757",
                        "description": "The metabolism of Istradefylline can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01410",
                        "description": "The metabolism of Ciclesonide can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB04889",
                        "description": "The metabolism of Bicifadine can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The metabolism of Antipyrine can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The metabolism of Erlotinib can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The metabolism of Astemizole can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Tamoxifen"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The metabolism of Pimozide can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Dacomitinib"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The metabolism of Mesoridazine can be decreased when combined with Enasidenib"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The metabolism of Trabectedin can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The metabolism of Ponatinib can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00277",
                        "description": "The metabolism of Theophylline can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "The metabolism of Sotalol can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The metabolism of Procainamide can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01195",
                        "description": "The metabolism of Flecainide can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00260",
                        "description": "Cycloserine may increase the neurotoxic activities of Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "Teniposide may increase the neurotoxic activities of Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "Cyclophosphamide may increase the neurotoxic activities of Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "Vincristine may increase the neurotoxic activities of Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00649",
                        "description": "Stavudine may increase the neurotoxic activities of Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00900",
                        "description": "Didanosine may increase the neurotoxic activities of Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01190",
                        "description": "Mesoridazine may increase the neurotoxic activities of Clindamycin"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "Mesoridazine may increase the neurotoxic activities of Paclitaxel"
                    },
                    {
                        "drugbank-id": "DB01294",
                        "description": "Mesoridazine may increase the neurotoxic activities of Bismuth subsalicylate"
                    },
                    {
                        "drugbank-id": "DB01598",
                        "description": "Mesoridazine may increase the neurotoxic activities of Imipenem"
                    },
                    {
                        "drugbank-id": "DB01627",
                        "description": "Mesoridazine may increase the neurotoxic activities of Lincomycin"
                    },
                    {
                        "drugbank-id": "DB09154",
                        "description": "Mesoridazine may increase the neurotoxic activities of Sodium citrate"
                    },
                    {
                        "drugbank-id": "DB09275",
                        "description": "Mesoridazine may increase the neurotoxic activities of Bismuth subcitrate potassium"
                    },
                    {
                        "drugbank-id": "DB11281",
                        "description": "Mesoridazine may increase the neurotoxic activities of Bismuth subcarbonate"
                    },
                    {
                        "drugbank-id": "DB11537",
                        "description": "Mesoridazine may increase the neurotoxic activities of Pirlimycin"
                    },
                    {
                        "drugbank-id": "DB13909",
                        "description": "Mesoridazine may increase the neurotoxic activities of Bismuth subgallate"
                    },
                    {
                        "drugbank-id": "DB13910",
                        "description": "Mesoridazine may increase the neurotoxic activities of Valproate bismuth"
                    },
                    {
                        "drugbank-id": "DB00781",
                        "description": "Mesoridazine may increase the neurotoxic activities of Polymyxin B"
                    },
                    {
                        "drugbank-id": "DB00994",
                        "description": "Mesoridazine may increase the neurotoxic activities of Neomycin"
                    },
                    {
                        "drugbank-id": "DB06827",
                        "description": "Mesoridazine may increase the neurotoxic activities of Viomycin"
                    },
                    {
                        "drugbank-id": "DB15965",
                        "description": "Mesoridazine may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB05077",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB06155",
                        "description": "The risk or severity of adverse effects can be increased when Rimonabant is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB06624",
                        "description": "The risk or severity of adverse effects can be increased when Taranabant is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11903",
                        "description": "The risk or severity of adverse effects can be increased when GW842166 is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB12193",
                        "description": "The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB12649",
                        "description": "The risk or severity of adverse effects can be increased when Ibipinabant is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13070",
                        "description": "The risk or severity of adverse effects can be increased when Surinabant is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "The risk or severity of adverse effects can be increased when WIN 55212 2 is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "The risk or severity of adverse effects can be increased when Nabiximols is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB14043",
                        "description": "The risk or severity of adverse effects can be increased when Palmidrol is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB14737",
                        "description": "The risk or severity of adverse effects can be increased when Cannabinol is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The therapeutic efficacy of Mesoridazine can be decreased when used in combination with Gilteritinib"
                    },
                    {
                        "drugbank-id": "DB00005",
                        "description": "The metabolism of Mesoridazine can be increased when combined with Etanercept"
                    },
                    {
                        "drugbank-id": "DB00026",
                        "description": "The metabolism of Mesoridazine can be increased when combined with Anakinra"
                    },
                    {
                        "drugbank-id": "DB00051",
                        "description": "The metabolism of Mesoridazine can be increased when combined with Adalimumab"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The metabolism of Mesoridazine can be increased when combined with Infliximab"
                    },
                    {
                        "drugbank-id": "DB01281",
                        "description": "The metabolism of Mesoridazine can be increased when combined with Abatacept"
                    },
                    {
                        "drugbank-id": "DB04956",
                        "description": "The metabolism of Mesoridazine can be increased when combined with Afelimomab"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "The metabolism of Mesoridazine can be increased when combined with Apremilast"
                    },
                    {
                        "drugbank-id": "DB06168",
                        "description": "The metabolism of Mesoridazine can be increased when combined with Canakinumab"
                    },
                    {
                        "drugbank-id": "DB06273",
                        "description": "The metabolism of Mesoridazine can be increased when combined with Tocilizumab"
                    },
                    {
                        "drugbank-id": "DB06372",
                        "description": "The metabolism of Mesoridazine can be increased when combined with Rilonacept"
                    },
                    {
                        "drugbank-id": "DB06674",
                        "description": "The metabolism of Mesoridazine can be increased when combined with Golimumab"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The metabolism of Mesoridazine can be increased when combined with Certolizumab pegol"
                    },
                    {
                        "drugbank-id": "DB09029",
                        "description": "The metabolism of Mesoridazine can be increased when combined with Secukinumab"
                    },
                    {
                        "drugbank-id": "DB09036",
                        "description": "The metabolism of Mesoridazine can be increased when combined with Siltuximab"
                    },
                    {
                        "drugbank-id": "DB14724",
                        "description": "The metabolism of Mesoridazine can be increased when combined with Emapalumab"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "The therapeutic efficacy of Dihydroergotamine can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00800",
                        "description": "The therapeutic efficacy of Fenoldopam can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01049",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11273",
                        "description": "The therapeutic efficacy of Dihydroergocornine can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB12313",
                        "description": "The therapeutic efficacy of Dopexamine can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB12890",
                        "description": "The therapeutic efficacy of Dihydrexidine can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13520",
                        "description": "The therapeutic efficacy of Metergoline can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00268",
                        "description": "The therapeutic efficacy of Ropinirole can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Benzatropine"
                    },
                    {
                        "drugbank-id": "DB11823",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Esketamine"
                    },
                    {
                        "drugbank-id": "DB00395",
                        "description": "The risk or severity of adverse effects can be increased when Carisoprodol is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00413",
                        "description": "The therapeutic efficacy of Pramipexole can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "The risk or severity of CNS depression can be increased when Mesoridazine is combined with Eszopiclone"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The risk or severity of sedation can be increased when Clonidine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of QTc prolongation can be increased when Trazodone is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "Pitolisant may increase the QTc prolonging activities of Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "Lefamulin may increase the QTc prolonging activities of Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00222",
                        "description": "The therapeutic efficacy of Glimepiride can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00414",
                        "description": "The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00672",
                        "description": "The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00839",
                        "description": "The therapeutic efficacy of Tolazamide can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01016",
                        "description": "The therapeutic efficacy of Glyburide can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01067",
                        "description": "The therapeutic efficacy of Glipizide can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01120",
                        "description": "The therapeutic efficacy of Gliclazide can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01124",
                        "description": "The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01251",
                        "description": "The therapeutic efficacy of Gliquidone can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01289",
                        "description": "The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB08962",
                        "description": "The therapeutic efficacy of Glibornuride can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13406",
                        "description": "The therapeutic efficacy of Carbutamide can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13675",
                        "description": "The therapeutic efficacy of Metahexamide can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00924",
                        "description": "The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The serum concentration of Escitalopram can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The metabolism of Dronedarone can be decreased when combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Lasmiditan"
                    },
                    {
                        "drugbank-id": "DB15066",
                        "description": "The serum concentration of Mesoridazine can be increased when it is combined with Givosiran"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The serum concentration of Mesoridazine can be increased when it is combined with Ranolazine"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The risk or severity of CNS depression can be increased when Mesoridazine is combined with Tramadol"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of extrapyramidal symptoms can be increased when Linezolid is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of extrapyramidal symptoms can be increased when Procarbazine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The risk or severity of extrapyramidal symptoms can be increased when Mesoridazine is combined with Amphetamine"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "The risk or severity of extrapyramidal symptoms can be increased when Furazolidone is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "The risk or severity of extrapyramidal symptoms can be increased when Procaine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "The risk or severity of extrapyramidal symptoms can be increased when Mesoridazine is combined with Pargyline"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "The risk or severity of extrapyramidal symptoms can be increased when Mesoridazine is combined with 7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The risk or severity of extrapyramidal symptoms can be increased when Mesoridazine is combined with Methylene blue"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "The risk or severity of extrapyramidal symptoms can be increased when Mesoridazine is combined with Hydracarbazine"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "The risk or severity of extrapyramidal symptoms can be increased when Mesoridazine is combined with Benmoxin"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "The risk or severity of extrapyramidal symptoms can be increased when Mesoridazine is combined with Mebanazine"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "The risk or severity of extrapyramidal symptoms can be increased when Mesoridazine is combined with Octamoxin"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "The risk or severity of extrapyramidal symptoms can be increased when Mesoridazine is combined with Pheniprazine"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "The risk or severity of extrapyramidal symptoms can be increased when Mesoridazine is combined with Phenoxypropazine"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "The risk or severity of extrapyramidal symptoms can be increased when Mesoridazine is combined with Pivhydrazine"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "The risk or severity of extrapyramidal symptoms can be increased when Mesoridazine is combined with Safrazine"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "The risk or severity of extrapyramidal symptoms can be increased when Mesoridazine is combined with Caroxazone"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "The risk or severity of extrapyramidal symptoms can be increased when Mesoridazine is combined with Harmaline"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "The risk or severity of extrapyramidal symptoms can be increased when Mesoridazine is combined with Brofaromine"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The risk or severity of extrapyramidal symptoms can be increased when Phenelzine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "The risk or severity of extrapyramidal symptoms can be increased when Minaprine is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The risk or severity of extrapyramidal symptoms can be increased when Mesoridazine is combined with Moclobemide"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "The risk or severity of extrapyramidal symptoms can be increased when Mesoridazine is combined with Isocarboxazid"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "The risk or severity of extrapyramidal symptoms can be increased when Mesoridazine is combined with Clorgiline"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "The risk or severity of extrapyramidal symptoms can be increased when Mesoridazine is combined with Iproniazid"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "The risk or severity of extrapyramidal symptoms can be increased when Mesoridazine is combined with Nialamide"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "The risk or severity of extrapyramidal symptoms can be increased when Mesoridazine is combined with Pirlindole"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "The risk or severity of extrapyramidal symptoms can be increased when Mesoridazine is combined with Toloxatone"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The serum concentration of Mesoridazine can be increased when it is combined with Phenytoin"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The serum concentration of Fosphenytoin can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "The serum concentration of Dimetacrine can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13114",
                        "description": "The serum concentration of Amitriptylinoxide can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13246",
                        "description": "The serum concentration of Quinupramine can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13384",
                        "description": "The serum concentration of Melitracen can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13782",
                        "description": "The serum concentration of Imipramine oxide can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The serum concentration of Mesoridazine can be increased when it is combined with Protriptyline"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The serum concentration of Mesoridazine can be increased when it is combined with Nortriptyline"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The serum concentration of Mesoridazine can be increased when it is combined with Amoxapine"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The serum concentration of Mesoridazine can be increased when it is combined with Trimipramine"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The serum concentration of Clomipramine can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB04836",
                        "description": "The serum concentration of Amineptine can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The serum concentration of Butriptyline can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The serum concentration of Tianeptine can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB09307",
                        "description": "The serum concentration of Oxaprotiline can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "The serum concentration of Opipramol can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13225",
                        "description": "The serum concentration of Dibenzepin can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13411",
                        "description": "The serum concentration of Lofepramine can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB13496",
                        "description": "The serum concentration of Iprindole can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The serum concentration of Amitriptyline can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "The serum concentration of Doxepin can be increased when it is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB06283",
                        "description": "The risk or severity of CNS depression can be increased when Mesoridazine is combined with Ziconotide"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The serum concentration of Mesoridazine can be increased when it is combined with Fluoxetine"
                    },
                    {
                        "drugbank-id": "DB14881",
                        "description": "The risk or severity of hypotension sedation death somnolence and respiratory depression can be increased when Mesoridazine is combined with Oliceridine"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}